HRCM
TGTX icon

Hood River Capital Management’s TG Therapeutics TGTX Stock Holding History

Hood River Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.9M Buy
1,600,510
+31,339
+2% +$1.28M 0.64% 54
2026
Q1 		$52.1M Sell
1,569,171
-12,063
-0.8% -$359K 0.52% 66
2025
Q4 		$47.1M Buy
1,581,234
+28,446
+2% +$929K 0.52% 67
2025
Q3 		$56.1M Sell
1,552,788
-14,718
-0.9% -$485K 0.66% 56
2025
Q2 		$56.4M Buy
1,567,506
+11,018
+0.7% +$410K 0.79% 46
2025
Q1 		$61.4M Buy
1,556,488
+101,165
+7% +$3.4M 1.05% 38
2024
Q4 		$43.8M Sell
1,455,323
-175,026
-11% -$5.02M 0.65% 63
2024
Q3 		$38.1M Buy
1,630,349
+57,420
+4% +$1.25M 0.62% 63
2024
Q2 		$28M Buy
1,572,929
+98,892
+7% +$1.58M 0.58% 64
2024
Q1 		$22.4M Buy
+1,474,037
New +$23.5M 0.5% 69
2023
Q2 		– Sell
-739,112
Closed -$11.1M – 145
2023
Q1 		$11.1M Buy
+739,112
New +$11.2M 0.36% 72
2022
Q1 		– Sell
-963,762
Closed -$18.3M – 160
2021
Q4 		$18.3M Buy
963,762
+609,756
+172% +$15.8M 0.55% 64
2021
Q3 		$11.8M Sell
354,006
-13,498
-4% -$418K 0.36% 77
2021
Q2 		$14.3M Sell
367,504
-5,234
-1% -$206K 0.42% 78
2021
Q1 		$18M Buy
+372,738
New +$17.9M 0.58% 69

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Hood River Capital Management's TGTX Position: Q2 2026 in Review

Hood River Capital Management increased its TG Therapeutics (TGTX) stake by 2% in Q2 2026, buying an estimated $1.28M and bringing the position to 1,600,510 shares worth $87.9M. The position accounts for 0.64% of the portfolio, ranked #54.

Hood River Capital Management first reported a position in TGTX in Q1 2021 and has held it in 15 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Hood River Capital Management held 1,600,510 shares of TG Therapeutics worth $87.9M as of Q2 2026.
  • Hood River Capital Management bought 31,339 TG Therapeutics shares in Q2 2026, an estimated $1.28M.
  • TG Therapeutics made up 0.64% of Hood River Capital Management's portfolio in Q2 2026, its #54 holding.
  • Hood River Capital Management first reported a position in TG Therapeutics in Q1 2021 and has held it in 15 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Hood River Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.